- $265.35m
- $830.26m
- $0.43m
Brief: Movano Health Announces Proposed Public Offering
Brief: Movano Health Provides Business Update And Reports Fourth Quarter 2022 Financial Results
Brief: Movano Health Completes $7.5 Million Public Offering
Brief: Movano Health Prices $6.5 Million Public Offering
Brief: Movano Health Announces Proposed Public Offering
U.S. STOCKS ON THE MOVE-Pfizer, Harrow Health, Vallon Pharma
Movano up on positive preliminary trial data for women health wearable
Brief: Movano Health Files First FDA Submission For Its Smart Ring's SpO2, Heart Rate Data
Brief: Movano Health Provides Business Update, Reports Third Quarter 2022 Financial Results
Brief: Movano Inc Reports Net Loss Attributable To Common Stockholders Of $0.26 Per Share In Q3
Brief: Movano Reports Second Quarter 2022 Financial Results
Brief: Movano Announces Beta Program With Stanford University
Brief: Movano Reports First Quarter 2022 Financial Results
Brief: Movano Successfully Completes Functional Testing of Smallest Ever Custom mmWave Sensor Designed for Non-Invasive Glucose and Cuffless Blood Pressure Monitoring
Brief: Movano Inc - On April 15, Approved An Increase In Size Of Board From Five To Six Directors
Brief: Movano Inc Files For Mixed Shelf Of Up To $100 Million – SEC Filing
Brief: Movano Reports Fourth Quarter 2021 Financial Results
Brief: Movano Strengthens IP For Its Non-Invasive Sensor Technology With 3 New U.S. Patents
Brief: Movano Inc. Provides Business Update And Reports Third Quarter 2021 Financial Results